{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q05513",
      "entity_text" : "PRKCZ",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0159" ],
      "Cellular_component" : [ "go:GO:0005694" ],
      "Organ" : [ "uberon:UBERON:0001092" ]
    }
  },
  "verbose_text" : "To do that, we used The Cancer Genome Atlas network colon adenocarcinoma dataset (TCGA-COAD) and selected patients in the top and bottom 25% of PRKCZ mRNA expression levels.",
  "reading_complete" : "2020-08-08T18:14:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:12:44Z",
  "trigger" : "levels",
  "evidence" : [ "PRKCZ mRNA expression levels" ],
  "pmc_id" : "5958623",
  "score" : 0
}